Bollschweiler E - Search Results

1

Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.

Alakus H, Grass G, Hennecken JK, Bollschweiler E, Schulte C, Drebber U, Baldus SE, Metzger R, Hölscher AH, Mönig SP. Alakus H, et al. Among authors: bollschweiler e. Histol Histopathol. 2008 Aug;23(8):917-23. doi: 10.14670/HH-23.917. Histol Histopathol. 2008. PMID: 18498066

2

Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis.

Mönig S, Baldus SE, Collet PH, Zirbes TK, Bollschweiler E, Thiele J, Dienes HP, Hölscher AH. Mönig S, et al. Among authors: bollschweiler e. Anticancer Res. 2001 Jan-Feb;21(1B):617-20. Anticancer Res. 2001. PMID: 11299815

3

Is the urokinase-type plasminogen activator system a reliable prognostic factor in gastric cancer?

Luebke T, Baldus SE, Spieker D, Grass G, Bollschweiler E, Schneider PM, Thiele J, Dienes HP, Hoelscher AH, Moenig SP. Luebke T, et al. Among authors: bollschweiler e. Int J Biol Markers. 2006 Jul-Sep;21(3):162-9. doi: 10.1177/172460080602100305. Int J Biol Markers. 2006. PMID: 17013798 Free article.

4

Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancer.

Ling FC, Baldus SE, Khochfar J, Xi H, Neiss S, Brabender J, Metzger R, Drebber U, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM. Ling FC, et al. Among authors: bollschweiler e. Histopathology. 2007 Jan;50(2):203-9. doi: 10.1111/j.1365-2559.2007.02576.x. Histopathology. 2007. PMID: 17222248

5

[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer.

Vallböhmer D, Hölscher AH, Schneider PM, Schmidt M, Dietlein M, Bollschweiler E, Baldus S, Alakus H, Brabender J, Metzger R, Mönig SP. Vallböhmer D, et al. Among authors: bollschweiler e. J Surg Oncol. 2010 Aug 1;102(2):135-40. doi: 10.1002/jso.21592. J Surg Oncol. 2010. PMID: 20648583 Clinical Trial.

6

Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.

Hölscher AH, Drebber U, Schmidt H, Bollschweiler E. Hölscher AH, et al. Among authors: bollschweiler e. Ann Surg. 2014 Nov;260(5):779-84; discussion 784-5. doi: 10.1097/SLA.0000000000000964. Ann Surg. 2014. PMID: 25379849

7

Carcinoma of the gastric cardia.

Hölscher AH, Bollschweiler E, Siewert JR. Hölscher AH, et al. Among authors: bollschweiler e. Ann Chir Gynaecol. 1995;84(2):185-92. Ann Chir Gynaecol. 1995. PMID: 7574379

8

Prognostic differences between early squamous-cell and adenocarcinoma of the esophagus.

Hölscher AH, Bollschweiler E, Schröder W, Gutschow C, Siewert J. Hölscher AH, et al. Among authors: bollschweiler e. Dis Esophagus. 1997 Jul;10(3):179-84. doi: 10.1093/dote/10.3.179. Dis Esophagus. 1997. PMID: 9280076 Review. No abstract available.

9

[Barrett and stomach carcinoma: surgical guidelines].

Hölscher AH, Bollschweiler E, Beckurts KT, Schneider PM. Hölscher AH, et al. Among authors: bollschweiler e. Langenbecks Arch Chir Suppl Kongressbd. 1998;115:304-11. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 9931630 Review. German.

10

[Carcinoma of the esophagus--actual epidemiology in Germany].

Bollschweiler E, Hölscher AH. Bollschweiler E, et al. Onkologie. 2001 Apr;24(2):180-4. doi: 10.1159/000050312. Onkologie. 2001. PMID: 11441301 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters